Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels – updated overview and meta-analyses of randomized trials

Cited by (296)

Items 201–296 of 296

1. Stroke prevention in patients with arterial hypertension: Recommendations of the Spanish Society of Neurology's Stroke Study Group
   Manuel Rodríguez‐Yáñez, Manuel Jesús Gómez-Choco, Elena López-Cancio M., Sergio Amaro, M. Alonso de Leciñana, Juan Francisco Arenillas, Óscar Ayo Martín, Mar Castellanos, M.M. Freijo, Á. García Pastor et al. · 2021 · Neurología (English Edition)
2. Baseline risk and outcome benefit from intensive blood pressure targeting. A systematic review
   Paolo Verdecchia, Fabio Angeli, Gianpaolo Reboldi · 2025 · European Journal of Internal Medicine
3. Impact of aortic rather than brachial pulsatile haemodynamics on variations in end-organ measures across the full adult blood pressure range
   Bryan Hodson, Gavin Robert Norton, Imraan Ballim, Carlos D. Libhaber, Pinhas Sareli, Angela J. Woodiwiss · 2017 · Journal of Hypertension
4. Which Target Blood Pressure in Year 2018? Evidence from Recent Clinical Trials
   Sondre Heimark, Julian Eek Mariampillai, Krzysztof Narkiewicz, Peter M. Nilsson, Sverre Erik Kjeldsen · 2018 · High Blood Pressure & Cardiovascular Prevention
5. Pharmacist‐led hypertension management combined with blood pressure telemonitoring in a primary care setting may be cost‐effective in high‐risk patients
   Stefano Omboni · 2018 · Journal of Clinical Hypertension
6. Pharmacotherapy of hypertension in patients with pre-dialysis chronic kidney disease
   Charalampos Loutradis, Pantelis A. Sarafidis · 2020 · Expert Opinion on Pharmacotherapy
7. First Line CombinAtion Therapy in the Treatment of Stage II and III Hypertension (FLASH)
   David Spirk, Sarah Noll, Michel Burnier, Stefano F. Rimoldi, Georg Noll, Isabella Sudano · 2020 · Frontiers in Cardiovascular Medicine
8. Prevalence of office and ambulatory hypotension in treated hypertensive patients with coronary disease
   J.A. Divisón, Juan J. de la Cruz, Alejandro de la Sierra, Ernest Vinyoles, Manuel Gorostidi, Carlos Escobar-Cervantes, J. Segura, Vivencio Barrios, Luis Miguel Ruilope, José R. Banegas · 2020 · Hypertension Research
9. Evaluation of time delay between discovery of a high blood pressure in a health screening survey and hypertension diagnosis
   Hassan Imam, Johan Sundström, Lars Lind · 2020 · Blood Pressure
10. Impact of Guidelines on Hypertension Control in the Elderly
    Del Pinto Rita, Mirela A. Dobre, Silvia Pagliacci, Claudio Ferri · 2020 · Current Pharmaceutical Design
11. The repercussion of stopping reimbursement of olmésartan on antihypertensive drugs prescription and blood pressure control of treated hypertensive patients in France
    Alexandre Dufay, Antonio Gallo, Olivier Hanon, Bernard Vaisse, Xavier J. Girerd · 2018 · Annales de Cardiologie et d Angéiologie
12. Kommentar zu den Leitlinien (2018) der Europäischen Gesellschaft für Kardiologie (ESC) und der Europäischen Gesellschaft für Hypertonie (ESH) für das Management der arteriellen Hypertonie
    Felix Mahfoud, Michael Böhm, Christa Bongarth, Ralph Bosch, Roland Erich Schmieder, Heribert Schunkert, Christoph Stellbrink, Peter Trenkwalder, Oliver Vonend, Joachim Weil et al. · 2019 · Der Kardiologe
13. Elevated On-Treatment Diastolic Blood Pressure and Cardiovascular Outcomes in the Presence of Achieved Systolic Blood Pressure Targets
    Dae‐Hee Kim, In‐Jeong Cho, Woohyeun Kim, Chan Joo Lee, Hyeon Chang Kim, Jeong‐Hun Shin, Si‐Hyuck Kang, Mi‐Hyang Jung, Chang Hee Kwon, Ju‐Hee Lee et al. · 2022 · Korean Circulation Journal
14. Clinical Pharmacokinetics and Pharmacodynamics of Baxdrostat
    Jessica Huston, Dontia Orey, Ashish Kumar, Andrew Ashchi, Andrea Ashchi, Jason Berner, Yazan Alkhouri, DAVID R. SUTTON, Wasim Deeb, Mohannad B. Bisharat et al. · 2024 · American Journal of Cardiovascular Drugs
15. PROBLEMS OF EVALUATING BLOOD PRESSURE MEASUREMENT IN MODERN CLINICAL TRIALS (THE CASE OF SPRINT STUDY RESULTS)
    Vladimir M. Gorbunov · 2018 · Rational Pharmacotherapy in Cardiology
16. Quality of care in patients with hypertension: a retrospective cohort study of primary care routine data in Germany
    Christoph Strumann, Nicola Engler, Wolfgang von Meißner, Paul-Georg Blickle, Jost Steinhäuser · 2024 · BMC Family Practice
17. Risk of fatal and nonfatal coronary heart disease and stroke events among adult patients with hypertension: basic Markov model inputs for evaluating cost-effectiveness of hypertension treatment: systematic review of cohort studies
    Mende Mensa Sorato, Majid Davari, Abbas Kebriaeezadeh, Nizal Sarrafzadegan, Tamiru Shibru, Behzad Fatemi · 2021 · Journal of Pharmaceutical Health Services Research
18. How low should blood pressure be in patients with chronic coronary and cerebrovascular diseases
    Athanasios John Manolis, Manolis S. Kallistratos, Miguel Camafort, António Coca · 2023 · European Journal of Internal Medicine
19. Strategies to improve blood pressure control: A step forward to winning the battle
    Speranza Donatella Rubattu · 2020 · International Journal of Cardiology Hypertension
20. Effects of Nicotinamide Mononucleotide Supplementation on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Mu Zhang, Yingci Chen, Nan Jiang, Jingjing Zeng, Jianyun Zhang, Chenyang Wu, Yingying Liu, Zizheng Nie, Jun Yang, Shufen Han · 2026 · Nutrients
21. Office white-coat effect tail and long-term cardiovascular risks in 60-year follow-up of the European cohorts of the Seven Countries Study
    Xavier Humbert, Andry Rabiaza, Anthony Kafatos, Paolo Piras, Hanna K Tolonen, Paolo Emilio Puddu · 2025 · Acta cardiologica. Supplementum
22. Impact of Intensive Blood Pressure Control Versus Standard Control on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Ufn Rizwanullah, Allenki Vineesh, Fardin Akbar Hyderi, Shivani Shah, Mihika Sawale, Tahera Ahmadi, Pavan Kumar Makam Surendraiah, Sneha Kanduri Hanumantharayudu, Fazeel Hussain, Chet Raj Awasthi et al. · 2025 · Cureus
23. A Risk Stratification Model for Predicting Benefits of Intensive Blood Pressure Treatment: Analysis of the Systolic Blood Pressure Intervention Trial
    Na Li, Zhixin Yang, Quan Yuan, Wen-Li Cheng · 2025 · Journal of Clinical Hypertension
24. The debate over the optimal blood pressure treatment target of less than 130/80 mmHg
    Steven G. Chrysant · 2022 · Postgraduate Medicine
25. [Integrated Care Protocol: Hypertension].
    Gabriela Borrayo–Sánchez, Martín Rosas-Peralta, María Cristina Guerrero-León, Héctor Galván‐Oseguera, Adolfo Chávez‐Mendoza, Juana Marlen Ruiz-Batalla, Joaquín Vargas-Peñafiel, Virginia Rosario Cortés-Casimiro, Nancy Xochitl Ramírez-Cruz, Carlos Alberto Soto-Chávez et al. · 2022 · PubMed Central
26. Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromes
    Emmanuelle Vidal‐Petiot, Yedid Elbez, Jules Mesnier, Grégory Ducrocq, Ian Ford, Michał Tendera, Roberto Ferrari, Jean‐Claude Tardif, Kim Michael Fox, Philippe Gabríel Steg · 2023 · European Journal of Preventive Cardiology
27. The Impact of Time-in-Target Range for Systolic Blood Pressure on Left Ventricular Hypertrophy
    Jianjiao Wang, Wen Li, Man Gui, Yang Liu, Siyu Wang, Shouling Wu, Wei Huang · 2025 · American Journal of Hypertension
28. Nurse Led Interventions in Hypertension
    Christopher Elles Clark · 2018 · Updates in hypertension and cardiovascular protection
29. Potential impact of 2018 Korean Society of Hypertension guidelines on Korean population: a population-based cohort study
    Ju-Seung Kwun, Sun–Hwa Kim, Si‐Hyuck Kang, Chang‐Hwan Yoon, Hae‐Young Lee, Kwang‐Il Kim, Tae‐Jin Youn, In‐Ho Chae, Cheol‐Ho Kim · 2020 · Clinical Hypertension
30. Impact du déremboursement de l’olmésartan chez les patients hypertendus en soins premiers
    Xavier Humbert, Andry Rabiaza, L. Schonbrodt, Thibaut Raginel, François Le Bas · 2020 · Annales de Cardiologie et d Angéiologie
31. Current features of management of comorbid patients with hypertension
    В. Н. Каретникова, Tatyana Nikolaevna Zvereva, О. Л. Барбараш · 2019 · Medical alphabet
32. El estudio SPRINT en la práctica clínica: ¿se debe modificar el objetivo de control de la presión arterial?
    Luis Miguel Ruilope, José R. Banegas · 2016 · Hipertensión y Riesgo Vascular
33. El SPRINT en la práctica médica: ¿es momento de modificar el manejo de la hipertensión arterial en Latinoamérica?
    José Gálvez-Olórtegui, Yudy Cley Cóndor-Rojas, Tomas Gálvez-Olortegui, Luis Arturo Camacho‐Saavedra · 2016 · Archivos de cardiología de México
34. Should This Patient Receive Aspirin?
    Risa Beth Burns, Kelly L. Graham, Mandeep Sawhney, Eileen E. Reynolds · 2017 · Annals of Internal Medicine
35. Abordaje terapéutico integral de la hipertensión arterial. Recomendaciones para Centroamérica y el Caribe
    Fernando Stuardo Wyss, Osiris Valdez, Miguel Camafort, António Coca · 2022 · Hipertensión y Riesgo Vascular
36. American and European Hypertension Guidelines: Finding Common Ground
    Eugene Yang, Garima V. Sharma, Venkata S. Ram · 2019 · The American Journal of Cardiology
37. Systolic blood pressure target less than 120 mmHg: the ‘Chariot Allegory’ in hypertension?
    Massimo Volpe, Giovanna Gallo · 2020 · Journal of Hypertension
38. Non-debatable issues in defining blood pressure targets for hypertension – Editorial
    Brent M. Egan, Sverre Erik Kjeldsen, Krzysztof Narkiewicz, Reinhold Hugo Kreutz, Michel Burnier, Giuseppe Mancia · 2025 · Blood Pressure
39. European Hypertension Guidelines: Similarities and What the Practicing Physician Should Keep in Mind
    Maria Elena Zeniodi, Θωμάς Τσαγανός, Ariadni Menti, Aikaterini Komnianou, Αναστάσιος Κόλλιας, Emelina Stambolliu · 2026 · Journal of Clinical Medicine
40. Lower is better in hypertension, but how low should blood pressure be targeted?
    Rhian M. Touyz · 2016 · Journal of the American Society of Hypertension
41. Impact of blood pressure early after allogeneic hematopoietic cell transplantation on clinical outcomes
    Masaharu Tamaki, Hideki Nakasone, Shunto Kawamura, Junko Takeshita, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Ayumi Gomyo, Aki Tanihara, Machiko Kusuda et al. · 2020 · Annals of Hematology
42. Most Recent Trials and Advances in Hypertension
    E. M. Rey-Rañal, A. Cordero · 2022 · European Cardiology
43. Efficacy and safety of ayurvedic intervention (Sarpgandha Mishran) vs amlodipine for Stage-I primary hypertension- study protocol for a prospective Double-Dummy, Double-Blind, placebo-controlled Randomized Clinical Trial
    Babita Yadav, BCS Rao, Rajiv Narang, Sophia Jameela, Shruti Khanduri, Sakshi Sharma, Drishya Dinesh, Arti Srivastava, Richa Bhardwaj, Bharti Gupta et al. · 2025 · BMC Complementary Medicine and Therapies
44. Renal dysfunction is associated with lower incidence of positive fractional flow reserve values in patients with severe hypertension
    László Hadadi, Răzvan Constantin Şerban, Tamás Juhász, Oana Țepeș, Cristina Somkereki, Zoltán Demjén, István Adorján, Silvia Lupu · 2020 · Minerva Cardioangiologica
45. Heart failure and the discrepancy between trials of intensive blood pressure management: an analysis of individual patient data
    Rahul Aggarwal, Haares Mirzan, Nicholas Chiu, Jackson Steinkamp · 2018 · Clinical Research in Cardiology
46. Meta‐analyses and blood pressure goals
    Staffan Björck, Karin Manhem, Annika Rosengren, Samuel Adamsson Eryd, Soffia Guðbjörnsdóttir, Stefan Franzén · 2018 · Journal of Clinical Hypertension
47. Hypertension and Its Ocular Manifestations
    Ivy Zhu, William F. Mieler, Stella K. Kim, Frederick A. Jakobiec · 2021 · Springer eBooks
48. Person-Centered Cardiology
    Dante E. Manyari, Israel Belenkie, Oscar Guillermo Quiroz · 2023 · Springer eBooks
49. Meta-Analysis in Renal Denervation – Or How to Compare Apples With Oranges?
    Felix Mahfoud, Felix Götzinger, Dominic Millenaar · 2021 · Cardiovascular revascularization medicine
50. Beta-blocker bashing and downgrading in hypertension management: a fashionable trend representing a matter of concern
    Reinhold Hugo Kreutz, Mattias Brunström, Michel Burnier, Guido M. Grassi, Andrzej Januszewicz, Sverre Erik Kjeldsen, María Lorenza Muiesan, Costas Thomopoulos, Konstantinos P Tsioufis, Giuseppe Mancia · 2024 · Journal of Hypertension
51. Population-level mortality benefits of hypothetical blood pressure lowering interventions in middle-aged and older Chinese adults: a modelling study
    Man Wang, Frank Qian, Xiaotong Chu, A L Li, Haibin Li · 2026 · QJM
52. Blood pressure goals revisited
    Vivencio Barrios, Carlos Escobar · 2016 · Journal of Hypertension
53. Target goal blood pressure in hypertension management
    Hae‐Young Lee · 2017 · Journal of Korean Medical Association
54. The efficiency of two-level electrovectorcardiographic diagnostics of left ventricular hypertrophy in the medical examination of urban and rural population
    Г В Рябыкина, N. A. Vishnyakova, Valentina S. Fedorova · 2021 · Systemic Hypertension
55. Pharmacological Management of Primary Arterial Hypertension: A Century of Expert Opinions in Cecil Textbook of Medicine
    Peter Manu, Liliana Marcela Rogozea, Andreea Cristina Ivănescu, Gheorghe‐Andrei Dan · 2022 · American Journal of Therapeutics
56. Intensive Blood Pressure Treatment Goals: Evidence for Cardiovascular Protection From Observational Studies and Clinical Trials
    Paul Kieran Whelton, Joshua D. Bundy, Robert M. Carey · 2022 · American Journal of Hypertension
57. Screening, Risikostratifizierung und CT-Bildgebung zur Abklärung der koronaren Herzkrankheit
    Leon Marcel Bischoff, Julian Alexander Luetkens · 2024 · Die Radiologie
58. Pharmacotherapies for Cardiovascular Disease Prevention
    Jennifer Ballard‐Hernandez, Colleen Walsh Irwin · 2024 · Springer eBooks
59. Treatment of arterial hypertension in patients with chronic kidney disease from the perspective of the 2023 European recommendations
    Сигитова Ольга Николаевна · 2024 · Kazan medical journal
60. Early vascular ageing as a new model to understand hypertension and arterial disease
    Peter M. Nilsson · 2016 · Cardiovascular Endocrinology
61. The Effect of Genetically Guided Mathematical Prediction and the Blood Pressure Response to Pharmacotherapy in Hypertension Patients
    Eli F. Kelley, Thomas Patrick Olson, Timothy B. Curry, Ryan S. Sprissler, Eric Michael Snyder · 2019 · Clinical Medicine Insights Cardiology
62. Considerations for Optimal Blood Pressure Target of Hypertension
    Qianhui Ling, Jun Cai · 2022 · Cardiology Discovery
63. Hypertension, diabetes and blood pressure targets: ongoing challenges
    Rhian M. Touyz · 2016 · Cardiovascular Endocrinology
64. 13. High Blood Pressure
    Leonelo E. Bautista · 2016 · American Public Health Association eBooks
65. Cibles de pression artérielle en néphrologie en 2017
    Dominique Guerrot, Michel Godin · 2017 · Néphrologie & Thérapeutique
66. What Is New and What Is Different in Recent Guidelines on Antihypertensive Treatment? Looking Forward to Guidelines Reappraisal
    Alberto Zanchetti · 2018 · Updates in hypertension and cardiovascular protection
67. What does fixed-dose triple-combination treatment for arterial hypertension bring us?
    Sonja Frančula-Zaninović · 2018 · Cardiologia Croatica
68. Hypertension Management for the Prevention of Heart Failure: Best Strategies
    Estefanía Oliveros, Karolina K. Marinescu, Tisha Marie B. Suboc, Kim Allan Williams Sr · 2018 · Current Cardiovascular Risk Reports
69. ¿Van a cambiar los objetivos de control de la hipertensión arterial?
    Miguel Camafort · 2017 · Hipertensión y Riesgo Vascular
70. Hipertensión al día en 6 preguntas. Curso precongreso SEH-LELHA Valencia 2016. Presentación
    Manuel Gorostidi, Francisco J. Morales‐Olivas · 2017 · Hipertensión y Riesgo Vascular
71. Arterial Hypertension: What Is the Optimal Goal of Treatment?
    Emmanuel A. Andreadis, Charalampia V. Geladari · 2018 · Springer eBooks
72. Prehypertension: A Case in Favor of Early Use of Diuretics
    Flávio Danni Fuchs, Sandra Cristina Pereira Costa Fuchs · 2018 · Updates in hypertension and cardiovascular protection
73. Knowledge about Systemic Arterial Hypertension in Employees of a Teaching Institution in the Metropolitan Region of Porto Alegre / RS
    Paulo Ricardo Marques Filho, Franciely Da Rosa Ferraz, Franciely Da Rosa Ferraz, Henry Güths, Henry Güths · 2019 · Journal of Health Sciences
74. Wearable Technology for Presumptive Diagnosis of High Blood Pressure Based on Risk Factors
    Eithel Josue Meza Prada, Helgar Miguel Angel Herrera Aguilar, Jimmy Armas-Aguirre, Paola A. González · 2020 · Smart innovation, systems and technologies
75. Экономическое обоснование затрат на снижение артериального давления при комплексной терапии артериальной гипертензии с приемом холекальциферола
    L. V. Yakubova, V. А. Snezhitskiy, В. П. Вдовиченко · 2021 · PAIN JOINTS SPINE
76. Blood pressure control—focusing on middle-aged women with elevated diastolic blood pressure
    Bernhard Rauch · 2021 · European Journal of Preventive Cardiology
77. THE ROLE OF HEMATOLOGICAL PARAMETERS AND AGE IN THE REMODELING OF THE HEART IN STAGE III ARTERIAL HYPERTENSION, DEPENDING ON GENDER, AGAINST THE BACKGROUND OF DRUG THERAPY
    L.N. Korichkina, V.N. Borodina, O. B. Poselyugina, N.I. Stebletsova, K.S. Ineshina, L.N. Al-Galban · 2021 · Современные проблемы науки и образования
78. Factors Associated with Masked Uncontrolled Arterial Hypertension in Patients Receiving Antihypertensive Treatment
    Катерина Миколаївна Амосова, Yuliia Rudenko · 2016 · Family Medicine
79. Rozpowszechnienie oraz kontrola leczenia nadciśnienia tętniczego u kobiet i mężczyzn włączonych do badania POLASPIRE w województwie mazowieckim
    Małgorzata Setny, Radosław Piątkowski, Arkadiusz Rak, Agnieszka Krzykwa, Piotr Kułak, Piotr Jankowski, DARIUSZ ARTUR KOSIOR · 2022 · Folia Cardiologica
80. DETERMINATION OF THE EFFECTIVENESS OF PERSONALIZED PHARMACOTHERAPY FOR ARTERIAL HYPERTENSION IN DIFFERENT CENTRAL NERVOUS SYSTEM ACTIVITY
    Г А Усенко, Н П Величко, A.V. Uskov, L.I. Makarova, D.A. Makhmudyan · 2021 · Sibirskij medicinskij vestnik
81. Ocena leczenia nadciśnienia tętniczego i czynników ryzyka ponownych hospitalizacji pacjentów z pierwotnym nadciśnieniem tętniczym hospitalizowanych z przyczyn kardiologicznych
    Kamil Janikowski, Aleksandra Paduszyńska, Marek Dąbrowa, Marek Maciejewski, Maciej Banach, Agata Magdalena Bielecka-Dabrowa · 2022 · Folia Cardiologica
82. Hypertension artérielle : qui traiter, jusqu’où et comment ?
    Olivier Steichen · 2023 · La Revue de Médecine Interne
83. Resistant arterial hypertension and treatment methods
    Igor Tomas · 2023 · Galenika Medical Journal
84. Development and effectiveness of an integrated medication management program centered on senior welfare centers for older adults with hypertension: A cross-sectional study
    Heuijeong Moon, Dukyoo Jung · 2023 · Journal of Korean Gerontological Nursing
85. Cerebrovascular Disease
    Philip B. Gorelick, Jiangyong Min, Muhammad Umar Farooq · 2023 · Elsevier eBooks
86. Meta-Analyses of Blood Pressure Lowering Trials
    George L. Bakris, Costas Thomopoulos · 2023 · Elsevier eBooks
87. Adherence to the Mediterranean Diet: Microbiota and Non-Communicable Diseases
    Sofi G. Julien, Mireille Serhan · 2024 · Frontiers research topics
88. Therapeutic Strategies to Prevent First Stroke
    Εugenia Gkaliagkousi, Antonios A. Lazaridis, Sotiria Spiliopoulou, Efstathios Manios · 2024 · Updates in hypertension and cardiovascular protection
89. Encouraged by the 2025 US Guidelines to Lower Systolic Blood Pressure Below 120 mm Hg: From Guidelines to Clinical Practice
    Paolo Verdecchia, Fabio Angeli, Gianpaolo Reboldi · 2025 · Hypertension
90. Is the next STEP on the BPROAD to intensive blood pressure lowering for all type 2 diabetic patients?: consensus statements from the Korean Society of Hypertension
    Eun Mi Lee, In‐Jeong Cho, Hae Jin Kim, Dae‐Hee Kim, Hae‐Young Lee, Sungha Park, Sang‐Hyun Ihm · 2025 · Clinical Hypertension
91. Additional file 1 of Clinical benefit of systolic blood pressure within the target range among patients with or without diabetes mellitus: a propensity score-matched analysis of two randomized clinical trials
    Li, Chao, Chen, Kangyu, Guoshuai Shi, Shi, Rui, Wu, Zhenqiang, Yuan, Xiaodan, Watson, Vicky, Jiang, Zhixin, Hui Mai, Yang, Tian et al. · 2022 · Figshare
92. Combined effects of exercise and diet interventions in patients with coronary artery disease: A systematic review and meta-analysis
    Petros C. Dinas, Constantine Zalagkitis, Marianthi Karaventza, Nikolaos Ntelis, Maria Papagianni, George S. Metsios · 2026 · Advanced Exercise and Health Science
93. Артериалната хипертония и мозъчно-съдова увреда
    Б. Кръстев · 2024 · Българска неврология
94. Antihypertensive Efficacy and Safety of Angiotensin Receptor Blockers (ARBs) with and without Inverse Agonism: A Systematic Review and Network Meta-analysis
    Jing Liu, Jialu Geng, Jiakun Liu, 胡 蕾, Du Huimin, I J Hung, Jia Fang · 2026 · American Journal of Cardiovascular Drugs
95. Blood pressure targets in adults with hypertension
    Doreen Yvonne Larvie, Wade Thompson, Guillaume Grenet, James Wright, Ciprian D Jauca, Douglas M Salzwedel, Stephen Adams, Anshula Ambasta · 2026 · Cochrane Database of Systematic Reviews
96. 2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.
    2022 · PubMed Central